ENTRY       D02784                      Drug
NAME        Agalsidase alfa (USAN/INN);
            Agalsidase alfa (genetical recombination) (JAN)
SEQUENCE    LDNGLARTPT MGWLHWERFM CNLDCQEEPD SCISEKLFME MAELMVSEGW KDAGYEYLCI
            DDCWMAPQRD SEGRLQADPQ RFPHGIRQLA NYVHSKGLKL GIYADVGNKT CAGFPGSFGY
            YDIDAQTFAD WGVDLLKFDG CYCDSLENLA DGYKHMSLAL NRTGRSIVYS CEWPLYMWPF
            QKPNYTEIRQ YCNHWRNFAD IDDSWKSIKS ILDWTSFNQE RIVDVAGPGG WNDPDMLVIG
            NFGLSWNQQV TQMALWAIMA APLFMSNDLR HISPQAKALL QDKDVIAINQ DPLGKQGYQL
            RQGDNFEVWE RPLSGLAWAV AMINRQEIGG PRSYTIAVAS LGKGVACNPA CFITQLLPVK
            RKLGFYEWTS RLRSHINPTG TVLLQLENTM QMSLKDLL
            (Glycosylation site: 108; 161; 184)
  TYPE      Peptide
REMARK      Therapeutic category: 3959
            ATC code: A16AB03
            Product: D02784<JP>
EFFICACY    Lysosomal storage disease treatment, Enzyme replacement (alpha-galactosidase)
  DISEASE   Fabry disease [DS:H00125]
  TYPE      Enzyme replacement therapy product
TARGET      GLA* [HSA_VAR:2717v1] [HSA:2717] [KO:K01189]
  PATHWAY   hsa00600(2717)  Sphingolipid metabolism
            hsa04142(2717)  Lysosome
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AB Enzymes
                 A16AB03 Agalsidase alfa
                  D02784  Agalsidase alfa (USAN/INN) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               395  Enzyme preparations
                3959  Others
                 D02784  Agalsidase alfa (USAN/INN); Agalsidase alfa (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Glycosidases
                GLA* [HSA_VAR:2717v1]
                 D02784  Agalsidase alfa (USAN/INN) &lt;JP&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D02784
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D02784
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D02784
DBLINKS     CAS: 104138-64-9
            PubChem: 17396942
///
